南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

KLF9介导的WTAP转录抑制通过M6A介导的CSF1R信号调控,驱动绝经后骨质疏松症患者破骨细胞形成

WTAP Transcriptional Suppression by KLF9 Drives Osteoclastogenesis via M6A-Mediated Regulation of CSF1R Signaling in Estrogen-Deficient Osteoporosis

Chen Shen, Xin Liu, Gaoran Ge, Li Xu, Ziyu Zhang, Chang Lv, Hao Xu, Wenhao Li, Yi Qin, Qifeng Sheng, Qihan Wang, Hongxia Li, Jun Zhou, Huilin Yang, Dechun Geng

Journal:Advanced Science

IF:14.1

DOI:10.1002/advs.77227

PMID:42669152

Published:2026-08-30

research field:RNA表观遗传学代谢性骨病破骨细胞分化骨生物学表观遗传学分子医学

Abstract

Osteoporosis, characterized by imbalanced bone homeostasis, is driven by excessive osteoclast-mediated bone resorption, yet the epitranscriptomic regulation via m 6 A modification remains unclear. Here, we identify WTAP, a component of the m 6 A methyltransferase complex, as a critical negative regulator of osteoclastogenesis. Myeloid-specific Wtap knockout in mice exacerbates osteoclast formation and osteoporotic bone loss. Mechanistically, WTAP mediates m 6 A deposition on Csflr mRNA, promoting degradation via the key m 6 A reader YTHDF2 and downregulating CSF1R expression, thereby enhancing osteoclastogenesis and bone loss in estrogen-deficient osteoporosis. We further discover that KLF9, induced during osteoclast differentiation, translocates to the nucleus to directly repress Wtap transcription, initiating this pathological process. Concurrent conditional knockout of KLF9 in osteoclast precursors rescues the exacerbated osteoporotic bone loss driven by myeloid-specific Wtap deficiency in vivo. This KLF9/WTAP/YTHDF2/m 6 A/CSF1R axis establishes a novel epigenetic circuit regulating bone resorption. Therapeutically, targeting this axis via AAV-mediated Wtap overexpression or pharmacological CSF1R inhibition with pexidartinib effectively ameliorates bone loss in osteoporotic mice. Our findings elucidate a previously unrecognized epitranscriptomic mechanism controlling osteoclastogenesis and highlight its therapeutic potential for pathological bone resorption.

本文使用的Yeasen产品

购物车
客服
转染试用